Incospharm Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 1

Incospharm General Information

Description

Producer of active ingredients intended to develop and supply high-quality ingredients to the pharmaceutical and cosmetic industries. The company develops peptides for anti-wrinkle, moisturizing, anti-oxidant, and brightening of the skin, enabling clients to make their own products.

Contact Information

Website
www.incospharm.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 Gukje Science 7-ro
  • Yuseong-gu
  • Daejeon, 34000
  • South Korea
+82
Primary Industry
Specialty Chemicals
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
LOHAS & Wellness
Corporate Office
  • 4 Gukje Science 7-ro
  • Yuseong-gu
  • Daejeon, 34000
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Incospharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round Completed Generating Revenue
To view Incospharm’s complete valuation and funding history, request access »

Incospharm Patents

  • 51

    Total Documents Applications and Grants

  • Total Patents Families

  • 34

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Incospharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4825865-A1 Peptide for improving skin condition through activation of hsp47 and cosmetic composition containing the same Pending 18-Apr-2025
US-20260347394-A1 Peptide for improving skin condition through activation of hsp47 and cosmetic composition containing the same Pending 18-Apr-2025
EP-4103147-A1 Composition for protecting the skin against harmful substance, light and stress Pending 24-Dec-2020
EP-4103147-A4 Composition for protecting the skin against harmful substance, light and stress Pending 24-Dec-2020
WO-2022139558-A1 Composition for protecting the skin against harmful substance, light and stress Inactive 24-Dec-2020 A61K31/198
To view Incospharm’s complete patent history, request access »

Incospharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Incospharm Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Reventures Venture Capital Minority
To view Incospharm’s complete investors history, request access »

Ready to get started?

Request a free trial

Incospharm FAQs

  • When was Incospharm founded?

    Incospharm was founded in 2011.

  • Where is Incospharm headquartered?

    Incospharm is headquartered in Daejeon, South Korea.

  • What is the size of Incospharm?

    Incospharm has 18 total employees.

  • What industry is Incospharm in?

    Incospharm’s primary industry is Specialty Chemicals.

  • Is Incospharm a private or public company?

    Incospharm is a Private company.

  • What is Incospharm’s current revenue?

    The current revenue for Incospharm is .

  • Who are Incospharm’s investors?

    Reventures has invested in Incospharm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process